Paroxysmal Supraventricular Tachycardia in a Neonate With COVID-19: A Case Report

Document Type : Case Report


1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran.

2 Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran.


COVID-19 is an infectious disease caused by SARS-CoV-2 that has significant potential cardiovascular implications for patients. Here, we describe a patient referred to Namazi Hospital, Shiraz, Iran, whose COVID-19 polymerase chain reaction test result was positive and developed paroxysmal supraventricular tachycardia. (Iranian Heart Journal 2023; 24(1): 104-107)


  1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109:102433
  2. Farnoosh G, Alishiri G, Hosseini Zijoud S R, Dorostkar R, Jalali Farahani A. Understanding the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Narrative Review. J Mil Med. 2020; 22 (1) :1-11
  3. Han D, Li R, Han Y, Zhang R, Li J. COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission. Int J Biol Sci. 2020; 16(15):2803-2811. Published 2020 Aug 27. doi:10.7150/ijbs.48991
  4. Bellini C, Gente M. 2020. Neonatal Transport and COVID-19 outbreak. Air Medical Journal. 2020. DOI:10.1016j.amj.2020.03.003.
  5. Posfay-Barbe KM, Wagner N, Gauthey M, et al. COVID-19 in children and the dynamics of infection in families. Pediatrics. 2020; 146(2):e20201576
  6. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020; 395 (10226): 809-815. DOI:10.1016/S0140-6736(20) 30360
  7. Wang W, Jiang TF, Han WZ, Jin L, Zhao XJ, Guo Y. Efficacy and economic benefits of a modified Valsalva maneuver in patients with paroxysmal supraventricular tachycardia. World J Clin Cases. 2020 Dec 6; 8(23):5999-6008. doi:10.12998/wjcc.v8.i23.5999. PMID:33344598; PMCID: PMC7723698.
  8. Yetkin E, Ozturk S, Cuglan B, Turhan H. Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptoms. Cardiovasc Endocrinol Metab. 2020 May 15; 9(4):153-158. doi:10.1097/XCE.0000000000000208. PMID: 33225230; PMCID: PMC7673777.
  9. Mazzone P, Peretto G, Radinovic A, Limite LR, Marzi A, Sala S, Cireddu M, Vegara P, Baratto F, Paglino G, D'Angelo G, Cianfanelli L, Altizio S, Lipartiti F, Frontera A, Bisceglia C, Gulletta S, Bella PD. The COVID-19 challenge to cardiac electrophysiologists: optimizing resources at a referral center. J Interv Card Electrophysiol. 2020 May 18:1-7. doi:10.1007/s10840-020-00761-7. Epub ahead of print. PMID: 32425656; PMCID: PMC7232930.
  10. Sunil Kumar Gulia, Dr. Rahul Kashyap, Dr. Rishabh Thakker, Dr. Ankit Chowdhry, Dr. Mylesh Ravisankar Dakshinamurthy, Dr. Sarine Dergarapet, Dr. Heena Tiwari. Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment: An Original Research. Annals of RSCB [Internet]. 2021Jun.23 [cited 2021Jul.21]; 25(6):13492-6. Available from:
  11. Han KY, Qiao Q, Zhu YQ, Chen XG, Kang XX, Zhang GF, Cai XC, Du Y, Jin J, Di RM, Yang CX, Zhang FX, Xu YJ. Atrial Arrhythmias in Patients with Severe COVID-19. Cardiol Res Pract. 2021 Mar 12; 2021:8874450. doi:10.1155/2021/8874450. PMID:33777449; PMCID: PMC7955658.